Machavert Pharmaceuticals Jacob Staszak Jirkovsky spoke with Christine Corrado from Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The Colorado-based bio-pharmaceutical company company develops new, first-in-class therapeutics that can harness the power of the human body to treat cancer and autoimmune diseases. The company’s primary goal is to improve the length and the quality of life of patients suffering from life threatening diseases, such as pancreatic cancer.
View full MACH profile View Profile
January 08 2019